Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,440 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07079839Recruiting
Anxiety and stress study for adults with PTSD
This study looks at how the brain processes anxiety and stress in people with PTSD and healthy adults. It uses brain scans and mild electrical stimulation to understand these responses better.
Houston, TexasAges 18–50 - NCT07082179RecruitingPhase 2
Immunotherapy plus chemotherapy for stage III lung cancer
This trial tests combining immunotherapy with chemotherapy for people with stage III non-small cell lung cancer that cannot be removed by surgery. It aims to see if this combination can shrink the tumor and improve outcomes.
NanjingAges 18–75 - NCT07079995Recruiting
Healthy School Program for Texas Students
This trial looks at a program called 'Healthy School Recognized Campus' to help schools in Central and East Texas improve student health. It tests how well the program works and how schools can use it, and your child may be able to join if they are in a public school in certain grades.
Dallas, TexasAges 8–16 - NCT07083804Recruiting
Testing for H. pylori using stool samples in children
This study checks if a stool test can find H. pylori bacteria in children, instead of using a stomach biopsy during an endoscopy. It may help diagnose stomach issues with less discomfort.
PoitiersAges Up to 16 years - NCT07083713Enrolling by invitation
Group coaching for life goals with chronic conditions
This study tests if group coaching helps people with certain chronic conditions set and achieve life goals. You would join phone or video sessions with a coach and others like you.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07077538Recruiting
Amino acid dialysis fluid for diabetic patients on PD
This study tests a special dialysis fluid made with amino acids (protein building blocks) instead of the usual sugar-based fluid. It may help control blood sugar and improve nutrition in people with diabetes on peritoneal dialysis.
Gaozhou, GuangdongAges 18–75 - NCT03180320Recruiting
Exercise program for chronic heart failure with confidence building
This trial studies whether a specific gentle exercise routine (Baduanjin, “eight-silken-movement”) plus skills to build self-confidence can help people with chronic heart failure. It’s meant for people who are stable and can do prescribed exercise testing and sessions.
Guangzhou, GuangdongAges 18 years+ - NCT04818203RecruitingPhase 1/Phase 2
Autologous fibroblast injections for crow’s feet wrinkles
This study tests a safety and effectiveness approach for reducing crow’s feet (wrinkles at the outer corners of the eyes) using cells made from your own skin. You may be asked to stop other wrinkle treatments and have blood tests and injections at a specific skin area.
SeoulAges 19 years+ - NCT05970497RecruitingPhase 1/Phase 2
KB707 trial for advanced solid tumors after other treatments
This early-stage trial tests KB707 in people with locally advanced or metastatic solid tumors that have not responded well to standard treatments. If you qualify, you may receive KB707 to see how well it can shrink tumors or control the disease.
Los Angeles, CaliforniaAges 18 years+ - NCT06330350Recruiting
Talking about family planning for genetic skin conditions
This study interviews people with inherited skin conditions (genodermatoses) who want to have children, and the doctors who care for them. The goal is to learn how to better support family planning decisions, like counseling about genetics and pregnancy risks.
Maastricht, LimburgAges Any age - NCT06474442RecruitingPhase 2
BD111 gene therapy for herpes simplex virus eye infection
This trial tests a new gene therapy called BD111 for people with a herpes simplex virus infection in the cornea (the clear front part of the eye). It aims to see if the treatment is safe and can help clear the virus, possibly improving vision.
Wenzhou, ZhejiangAges 18–70 - NCT06744296Recruiting
ctDNA surveillance for HPV-negative head and neck cancer
This trial uses a blood test to look for tiny bits of tumor DNA after treatment for head and neck cancer. It aims to see if this test can detect any remaining cancer cells early, so you and your doctor can make informed decisions.
Boston, MassachusettsAges 18 years+ - NCT06869265RecruitingPhase 2
Thiotepa added to standard chemo before a stem cell transplant for older adults with high-risk AML
This trial tests whether adding a drug called thiotepa to the usual chemotherapy (busulfan and fludarabine) before a half-matched stem cell transplant can safely and effectively treat older adults (55–70) with high-risk AML.
Beijing, Beijing MunicipalityAges 55–70 - NCT06978933RecruitingPhase 2
Testing two new drugs for FGF19-positive liver cancer
This trial tests two new targeted drugs (ABSK-011 and ABSK043) for people with advanced liver cancer whose tumors have high levels of the FGF19 protein and who have already tried at least one other treatment.
ShanghaiAges 18 years+ - NCT06874010RecruitingPhase 1/Phase 2
Study of DT-216P2 in adults with Friedreich's ataxia
This trial tests an investigational drug called DT-216P2 in people with Friedreich's ataxia. It aims to find the right dose and see how safe and tolerable it is.
Sydney, New South WalesAges 18–65 - NCT06926010Recruiting
Blood flow monitoring for carotid artery surgery
This trial is testing a special way to monitor blood flow during carotid artery surgery to help keep patients safe. It may be a good fit if you are having planned carotid surgery and meet a few basic health criteria.
RomeAges 18 years+ - NCT06977139Recruiting
Structural Heart Disease Registry Study in Lubeck
This study collects information from people with structural heart disease to learn more about their condition and treatments. It does not test a new drug or procedure—just observes your regular care.
Lübeck, Schleswig-HolsteinAges 18 years+ - NCT06977893RecruitingPhase 3
Chemo and immunotherapy for HR+ breast cancer before surgery
This trial tests whether adding the immunotherapy drug toripalimab to chemotherapy before surgery helps women with a certain type of breast cancer (HR+, HER2-). It aims to see if this combination works better than chemotherapy alone.
HangzhouAges 18–75 - NCT03033251Recruiting
Compare high-flow oxygen to noninvasive ventilation for COPD flare-ups
This study compares two breathing support options for people hospitalized with a COPD flare-up and high carbon dioxide levels in the blood. It aims to see which option works better and is safer for breathing and recovery.
Toronto, OntarioAges 40 years+ - NCT06978998Recruiting
Retinal photos to help predict heart failure outcomes
This study tests whether a simple eye photo can help doctors better predict the course of heart failure with reduced pumping strength. If it works, this low-cost test could improve care for people with this condition.
SeoulAges 20 years+ - NCT06977750Recruiting
Gelatin fluid for safe blood volume during surgery
This trial is testing a special fluid called succinylated gelatin (a type of colloid) given during surgery to help maintain blood volume. It is for people having planned surgery lasting less than 6 hours and who are in generally good health, without major heart, liver, or kidney problems.
Changsha, HunanAges 18–65 - NCT06978192RecruitingPhase 2
Study for treating shingles pain with a special nerve block
This trial tests a combination of two treatments to reduce shingles pain that hasn't responded to standard medicines. It involves a nerve block to see if it can help people who have ongoing pain after shingles.
Zunyi, GuizhouAges 40–85 - NCT06978400RecruitingPhase 2
Targeted therapy plus chemo for BRAF mutant colorectal cancer
This trial tests a combination of targeted therapy (dabrafenib) and two other drugs (cetuximab or panitumumab) plus standard chemotherapy (FOLFOX) as a first treatment for people with a specific type of metastatic colorectal cancer that has a BRAF V600E mutation and is microsatellite stable.
MoscowAges 18 years+ - NCT06978699RecruitingPhase 2
Testing XH-S003 for people with PNH
This trial tests a new medicine, XH-S003, for people with paroxysmal nocturnal hemoglobinuria (PNH) who have not tried complement inhibitors before. The goal is to see if it can help manage symptoms like low red blood cells and fatigue.
TianjinAges 18 years+
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,440 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.